Femasys Inc. (FEMY) intrinsic value & 10-year financials

Femasys Inc. (FEMY) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 17.2% a year to $2.3M, with an average return on invested capital of 337.6%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$1.65
Market cap
$65.3M
Revenue (FY2025)
$2.3M
Revenue growth (7-yr CAGR)
17.2%
ROIC (10-yr avg)
337.6%
Free cash flow (FY2025)
-$19.2M

FEMY 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $2.3M -$18.6M -$0.47 -$19.2M -767.0% 1762.6%
FY2024 $1.6M -$18.8M -$0.85 -$20.2M -1091.8% 3718.3%
FY2023 $1.1M -$14.2M -$0.93 -$11.4M -1353.4% -2955.6%
FY2022 $1.2M -$11.4M -$0.96 -$11.1M -961.7% -544.5%
FY2021 $1.2M -$7.5M -$1.12 -$8.2M -706.7% 31.8%
FY2020 $1.0M -$6.9M -$1.03 -$4.9M -668.0% 12.8%
FY2019 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

FEMASYS INC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

FEMASYS INC returns on capital have been average, hovering around 10.7% ROIC over the decade.

FEMASYS INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, FEMASYS INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-15.61 per share.

FEMY stock: frequently asked questions

What is the intrinsic value of Femasys Inc. (FEMY) stock?

Graham's formula only works with positive earnings. Femasys Inc. reported diluted EPS of -$0.47 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Femasys Inc. generate free cash flow?

Femasys Inc. generated -$19.2M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 6 reported years.

What is FEMY's return on invested capital?

Average ROIC over the last 7 fiscal years was 337.6%, and average return on equity was -117.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this FEMY data come from?

From Femasys Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 8, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks